This study demonstrates the variable expression of ICAM-1 and leukocyte fun
ction antigen-3 (LFA-3) on four tumor cell lines (COLO526, K562, Daudi, and
HT-29), In addition, phorbol ester (PMA) activation of lymphocytes modulat
ed LFA-1 from a uniform to a clustered surface distribution; whereas after
treatment with high levels of Mg2+ ions, the unique epitope for high-affini
ty LFA-1 was identified using clone Mab24. Using a flow cytometric adhesion
assay it was demonstrated that PMA-activated lymphocytes formed conjugates
with COLO526 and Daudi, and that these conjugates were inhibited by anti-C
D2 with varying inhibition by LFA-1 clones MHM24 and 25.3.1. When lymphocyt
es were induced to express the high-affinity form of LFA-1, conjugates were
identified with COLO526, K562, and Daudi and these conjugates were sensiti
ve to the presence of both CD2 and LFA-1 antibodies. Further studies using
confocal microscopy confirmed significant adhesion between peripheral blood
lymphocytes pretreated with either PMA or high levels of Mg2+ and the adhe
rent cell line COLO526, In conclusion, this unique study has demonstrated f
or the first time the important role of the active form of LFA-1 on the lym
phocyte cell surface for conjugate formation with an ICAM-1-expressing tumo
r cell; also, two pathways of cell signaling were identified for conjugate
formation to occur.